Filing Details
- Accession Number:
- 0001209191-20-008889
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-12 17:22:24
- Reporting Period:
- 2020-02-10
- Accepted Time:
- 2020-02-12 17:22:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1406338 | Amit Sachdev | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Chief Patient Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-10 | 12,215 | $240.95 | 59,268 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-02-11 | 1,000 | $243.53 | 58,268 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 3,426 | $245.05 | 54,842 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 4,320 | $245.99 | 50,522 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 1,821 | $246.88 | 48,701 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 2,103 | $247.98 | 46,598 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 400 | $248.73 | 46,198 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 16,190 | Indirect | Held in Trust |
| Common Stock | 882 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $243.53 (range $242.88 to $243.86).
- Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $245.05 (range $244.50 to $245.47).
- Open market sales reported on this line occurred at a weighted average price of $245.99 (range $245.50 to $246.45).
- Open market sales reported on this line occurred at a weighted average price of $246.88 (range $246.53 to $247.39).
- Open market sales reported on this line occurred at a weighted average price of $247.98 (range $247.55 to $248.50).
- Open market sales reported on this line occurred at a weighted average price of $248.73 (range $248.60 to $248.82).
Billionaire Hedge Funds
